Gotham Asset Management’s Intelligent Bio Solutions INBS Stock Holding History

Gotham Asset Management’s Portfolio INBS Stock Details INBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4	Closed	-$661K	–	1260
2022 Q3	$661K	Buy	+4	New	+$6.06K	0.02%	779

Other funds holding INBS

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Gotham Asset Management's INBS Position: Q4 2022 in Review

Gotham Asset Management sold out of Intelligent Bio Solutions (INBS) in Q4 2022, closing a stake of 4 shares — an estimated $661K sold.

Gotham Asset Management first reported a position in INBS in Q3 2022 and held it in 1 quarter. The position peaked at $661K in Q3 2022. 8 funds tracked by Wall St. Rank hold INBS as of Q4 2022.

Gotham Asset Management reported no remaining Intelligent Bio Solutions position as of Q4 2022 after selling out during the quarter.
Gotham Asset Management sold 4 Intelligent Bio Solutions shares in Q4 2022, an estimated $661K.
Gotham Asset Management first reported a position in Intelligent Bio Solutions in Q3 2022 and held it in 1 quarter.
Gotham Asset Management's Intelligent Bio Solutions position peaked at $661K in Q3 2022.
8 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q4 2022.

Based on Gotham Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.